ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Thus, the diminished adiponectin levels observed in individuals with obesity pose a tangible risk, fostering an environment conducive to uncontrolled cell proliferation and thereby cancer progression [79,80].